Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03382327
Other study ID # 16-003
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 16, 2017
Est. completion date October 16, 2020

Study information

Verified date February 2021
Source IHU Strasbourg
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to assess the benefit of 3D models in the planning of hepatic resection by comparing the changes in the surgical plan based on the analysis of conventional preoperative images (CT-scan and MRI), compared to the surgical plan based on the analysis of 3D reconstruction.


Description:

The detailed anatomical description of the liver described by Couinaud in 1954 is the basis for hepatic surgery. Surgical resection is the approach leading to the best survival rate in case of liver cancer. In hepatocarcinomas, systematic removal of the infected liver segment is considered the most effective technique to eliminate tumour, potential satellite nodules and avoid vascular spread. Resectability rate highly depends on the analysis of preoperative images. However, in 20% of cases, there are modifications compared with the initial surgical plan leading to an increase in morbidity rate. In 2002, Couinaud highlighted the difficulty of identifying portal pedicles, especially because of anatomical variations, and recommended the use of a three-dimensional reconstruction from images provided by a helical scanner. The hypothesis of the study is that 3D models would improve surgical planning leading to a decrease in intra-operative adjustments and mortality. The aim of this multicentric, prospective study is to assess the benefit of 3D models in the surgical management of hepatocarcinomas, more specifically in the detailed analysis of 3D vascular structures and in the surgery planning with resection merges evaluation. The validation of this virtual method will be built on the comparison of the surgical plan based on the analysis of conventional preoperative images (CT-scan and MRI) and the surgical plan based on the analysis of 3D reconstruction.


Recruitment information / eligibility

Status Completed
Enrollment 136
Est. completion date October 16, 2020
Est. primary completion date October 16, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient with a hepatocarcinoma, eligible for surgical resection - Patient over 18 years old - Patient able to understand the study and provide written informed consent - Patient affiliated to the French social security system. Exclusion Criteria: - Patient with other liver tumours - Patient whose general condition is not suitable for study participation (WHO = 3) - Patient with a condition preventing its participation to study procedures, according to investigator's judgment - Patient with contraindications to injected CT-scan or MRI: allergic reaction to contrast agents, kidney failure, pacemaker, claustrophobia - Pregnancy or breastfeeding - Patient in exclusion period (determined by a previous study or in progress) - Patient in custody - Patient under guardianship.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Surgical planning
Two surgical plans will be established preoperatively. The first plan will be based on standard preoperative images (CT-scan, MRI) review. The second plan will be based on the 3D model review. Both will be compared to the actual surgery performed in the operating room.

Locations

Country Name City State
France Service de Chirurgie Digestive - Hôpital Beaujon Clichy
France Hôpital Henri Mondor - Service de Chirurgie Digestive et Hépatobiliaire - Créteil
France Service de Chirurgie Digestive et Transplantation - Hôpital Claude Huriez Lille
France Service de Chirurgie Digestive et Transplantation Hépatique - Hôpital universitaire de la Croix-Rousse Lyon
France Service de Chirurgie Digestive - CH Emile Muller Mulhouse
France Chirurgie Viscérale et Digestive - Polyclinique de Gentilly Nancy
France Chirurgie Digestive, Hépato-bilio-pancréatique et Transplantation - La Pitié Sâlpêtrière Paris
France Service de Chirurgie Digestive - CHU Robert Debré Reims
France Service de Chirurgie Digestive Hôpital Charles Nicolle - CHU Rouen Rouen
France Institut de Chirurgie Viscérale - Clinique de l'Orangerie Strasbourg
France Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil Strasbourg
France Centre Hépato-Biliaire - Hôpital Paul Brousse Villejuif

Sponsors (1)

Lead Sponsor Collaborator
IHU Strasbourg

Country where clinical trial is conducted

France, 

References & Publications (4)

Couinaud C. [Errors in the topographic diagnosis of liver diseases]. Ann Chir. 2002 Jun;127(6):418-30. Review. French. — View Citation

Gauss T, Merckx P, Brasher C, Kavafyan J, Le Bihan E, Aussilhou B, Belghiti J, Mantz J. Deviation from a preoperative surgical and anaesthetic care plan is associated with increased risk of adverse intraoperative events in major abdominal surgery. Langenbecks Arch Surg. 2013 Feb;398(2):277-85. doi: 10.1007/s00423-012-1028-3. Epub 2012 Nov 13. — View Citation

Mutter D, Dallemagne B, Bailey Ch, Soler L, Marescaux J. 3D virtual reality and selective vascular control for laparoscopic left hepatic lobectomy. Surg Endosc. 2009 Feb;23(2):432-5. doi: 10.1007/s00464-008-9931-y. Epub 2008 Apr 29. — View Citation

Mutter D, Soler L, Marescaux J. Recent advances in liver imaging. Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):613-21. doi: 10.1586/egh.10.57. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of the intra-operative modifications rates Modifications in the surgical planning compared to the plan based on the analysis of standard preoperative images (CT-scan and MRI) and the plan based on the 3D model analysis: changes in surgical resection type (by specifying the surgical act: tumorectomy, segmentectomy, bi-segmentectomy or lobectomy…) or no surgery. At time of surgery
Secondary Comparison of tumor(s) location Comparison of tumor(s) location based on 3D model and standard preoperative images analysis. At time of surgery
Secondary Comparison of vascular network anatomy Comparison of vascular network anatomy based on 3D model and standard preoperative images analysis. At time of surgery
Secondary Choice of surgical plan Surgery done according to a) surgical plan based on standard preoperative images analysis, b) surgical plan based on 3D model analysis or c) alternative approach (by specifying the surgical act: tumorectomy, segmentectomy, bi-segmentectomy or lobectomy….) At time of surgery
Secondary Modification of the initial surgical plan, if applicable Description of perioperative events having modified the initial surgical plan. At time of surgery
Secondary Comparison of resection merges Comparison of expected resection merges based on standard preoperative images and 3D model analysis and actual resection merge in the operating room. At time of surgery
Secondary Comparison of resection volumes Comparison of expected resection volumes based on standard preoperative images and 3D model analysis and actual resection volume in the operating room. At time of surgery
Secondary Comparison of surgical merge size Comparison of surgical merge size (mm) based on 3D model and standard preoperative images analysis. At time of surgery
Secondary Morbidity Morbidity specific to the procedure. At time of surgery and 3 months after surgery
Secondary Mortality Mortality specific to the procedure. At time of surgery and 3 months after surgery
Secondary Preoperative images independent analysis Analysis of preoperative images (CT-scan/MRI and 3D model) by a senior team on one hand, and a junior team (surgeons + radiologists) on the other hand. 3 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06041490 - Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation Phase 2
Terminated NCT03956940 - Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib N/A
Recruiting NCT03755739 - Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors Phase 2/Phase 3
Recruiting NCT06028724 - A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
Not yet recruiting NCT03718078 - Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery N/A
Recruiting NCT05794048 - METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors N/A
Recruiting NCT04435977 - Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma Phase 2
Completed NCT04811898 - A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment Phase 1
Recruiting NCT05311319 - HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection Phase 2
Completed NCT05464706 - Study on the Quality of Life (QoL) After Liver Surgery N/A
Completed NCT01411579 - Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma N/A
Completed NCT02519075 - 11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE
Recruiting NCT03356236 - Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation